Thrombocytopenia, neonatal alloimmune Clinical Trials
Conditions / Thrombocytopenia, neonatal alloimmune
Delta Trials records 2 clinical trials for Thrombocytopenia, neonatal alloimmune in its publicly accessible dataset. From the full dataset, 2 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 44 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
2
Total Trials
2
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
44
Study Locations
Browse by location (44 total)
- Park Ridge, United States 1 trialAll trials in Park Ridge, United States
- Galveston, United States 1 trialAll trials in Galveston, United States
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States
- Łódź, Poland 1 trialAll trials in Łódź, Poland
- Birmingham, United States 1 trialAll trials in Birmingham, United States
- Graz, Austria 1 trialAll trials in Graz, Austria
- Trondheim, Norway 1 trialAll trials in Trondheim, Norway
- Paris, France 1 trialAll trials in Paris, France
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- Vienna, Austria 1 trialAll trials in Vienna, Austria
- Hanover, Germany 1 trialAll trials in Hanover, Germany
- Jena, Germany 1 trialAll trials in Jena, Germany
- Oslo, Norway 1 trialAll trials in Oslo, Norway
- Aurora, United States 1 trialAll trials in Aurora, United States
- Oxford, United Kingdom 1 trialAll trials in Oxford, United Kingdom
- Rome, Italy 1 trialAll trials in Rome, Italy
- Recife, Brazil 1 trialAll trials in Recife, Brazil
- Chapel Hill, United States 1 trialAll trials in Chapel Hill, United States
- Leuven, Belgium 1 trialAll trials in Leuven, Belgium
- Sacramento, United States 1 trialAll trials in Sacramento, United States